Desvenlafaxine Tablet, Extended Release
Product Images NDC 50090-6738

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Desvenlafaxine (NDC 50090-6738). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Des Structure)

Chemical Structure (Des Structure)
FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
Not available.*
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
This appears to be a graph showing the time to relapse in days from randomization and the estimated proportion of patients with relapse, comparing Desvenlafaxine Extended-Release Tablets (at a dose of 50mg) to a placebo. The graph also includes a scale from 0 to 200 on the x-axis.*
FDA Label Image

Figure-5 (Figure 5)

Figure-5 (Figure 5)
FDA Label Image

Label Image (Lbl500906738)

Label Image (Lbl500906738)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.